Clinical Trials for Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Find clinical trials for relapsed/refractory peripheral t-cell lymphoma (r/r ptcl). Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

NCT ID: NCT06909877

This clinical trial is studying a new oral medication called HH2853 for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), which is a type of cancer that affects the lymphatic ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Chengdu, China

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

NCT ID: NCT06855823

This clinical trial is investigating the combination of two medications, Golidocitinib and Pomalidomide, to see how effective and safe they are for patients with relapsed or refractory peripheral T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions